William Blair Initiates Coverage On Arcus Biosciences with Outperform Rating
10/16/2026
Impact: 70
Healthcare
William Blair analyst Alethia Young has initiated coverage on Arcus Biosciences (NYSE: RCUS) with an Outperform rating. This marks a positive outlook for the company in the market.
AI summary, not financial advice
Share: